The role of pacemaker algorithms in preventing atrial fibrillation progression
Автор: Abdelmoneum M.S., Aboul-enein H.M., Abdelhakeem A.S., Makled W.A.E., Darwish M.S.
Журнал: Cardiometry @cardiometry
Рубрика: Original research
Статья в выпуске: 23, 2022 года.
Бесплатный доступ
Background: Unnecessaryright ventricular (RV) pacing leads to cardiac dyssynchrony and increases the risk of developing permanent atrial fibrillation. Minimizing RV pacing by specefic algorithms decreases the AF risk. Aim and objectives: Our objective was to study the effect of pacemaker algorithms on atrial fibrillation progression. Subjects and Methods: Patients with dual chamber (group A) and single chamber (group B)pacemakers were included in the study. Patients with history of AF at the time of pacemaker implantation were not included in the study. The relation between pacemaker parameters and AF development was monitored. Result: Group A showed that RV pacing percentage had high significance for developing AF with P value P
Pacemaker algorithms, atrial fibrillation
Короткий адрес: https://sciup.org/148326571
IDR: 148326571 | DOI: 10.18137/cardiometry.2022.23.6475
Список литературы The role of pacemaker algorithms in preventing atrial fibrillation progression
- Nielsen JC, Thomsen PE, Højberg S, et al. DANPACE Investigators. A comparison of single-lead atrial pacing with dual-chamber pacing in sick sinus syndrome. Eur Heart J. 2011; 32: 686– 696.
- Sweeney MO, HellkampAS, EllenbogenKA, et al. Mode Selection Trial Investigators. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction.Circulation.2003;107:2932–2937.
- Shurrab M, Healey JS, Haj-Yahia S, et al. Reduction in unnecessary ventricular pacing fails to affect hard clinical outcomes in patients with preserved left ventricular function: a meta-analysis.Europace. 2017;19:282– 288.
- Nielsen JC, Thomsen PE, Højberg S, et al. DANPACE Investigators. Atrial fibrillation in patients with sick sinus syndrome: the association with PQ-interval and percentage of ventricular pacing. Europace. 2012; 14: 682– 689.Rhythm. 2015; 12: 2239– 2246.
- Boriani G, Pieragnoli P, Botto GL, et al. Effect of PR interval and pacing mode on persistent atrial fibrillation incidence in dual-chamber pacemaker patients: a sub-study of the international randomized MINERVA trial. Europace. 2019; 21: 636– 644.
- Brignole M, Auricchio A, Baron-Esquivias G, et al. ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J. 2013; 34(29): 2281– 2329.
- Dębski M, Ulman M, Ząbek A, Boczar K, Haberka K, Kuniewicz M, Lelakowski J, Małecka B. Permanent atrial fibrillation in patients with a dualchamber pacemaker. KardiologiaPolska (Polish Heart Journal). 2019; 77(12):1140-6.
- Castella M, Polychronis E, Jonathan M, Deirdre A, Arbelo E, Dagres N., et al. ESC Guidelines for the diagnosis and management of atrial fibrillation developed incollaboration with the European Association for Cardio-Thoracic Surgery (EACTS). European Heart Journal 2020; 42, 373_498.
- Alonso A, Jensen PN, Lopez FL, et al. Association of sick sinus syndrome with incident cardiovascular disease and mortality: the Atherosclerosis Risk in Communities study and Cardiovascular Health Study. PLoS One. 2014; 9: e109662.
- Sweeney MO, Bank AJ, Nsah E, Koullick M, Zeng QC, Hettrick D, Sheldon T, Lamas GA, Search AV. Extension and Managed Ventricular Pacing for Promoting Atrioventricular Conduction Trial. Minimizingventricular pacing to reduce atrial fibrillation in sinus- node disease. N Engl J Med 2007;357:1000_1008.
- Veasey RA, Arya A, Silberbauer J, Sharma V, Lloyd GW, Patel NR, Sulke AN. The relationship between right ventricular pacing and atrial fibrillation burden and disease progression in patients with paroxysmal atrial fibrillation: the long-MinVPACE study. Europace. 2011; 13(6): 815-20.
- Yadav R, Jaswal A, Chennapragada S, Kamath P, Hiremath SM, Kahali D, Anand S, Sood NK, Mishra A, Makkar JS, Kaul U. Effectiveness of Ventricular Intrinsic Preference (VIP™) and Ventricular AutoCapture (VAC) algorithms in pacemaker patients: Results of the validate study. Journal of Arrhythmia. 2016; 32(1):29-35.
- Wass SY, KanjM, Mayuga K, et al. Proarrhythmic effects from competitive atrial pacing and potential programming solutions. Pacing ClinElectrophysiol. 2020;43:720–729.
- Doundoulakis I, Gavriilaki M, Tsiachris D, Arsenos P, Antoniou CK, Dimou S, Soulaidopoulos S, Tsioufis K. Atrial High-Rate Episodes in Patients with Devices Without a History of Atrial Fibrillation: a Systematic Review and Meta-analysis. Cardiovasc Drugs Ther.2021.
